Skip to main content
SpringerLink
Log in

Effects of recombinant growth hormone (GH) treatment on bone mineral density and body composition in adults with childhood onset growth hormone deficiency

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Lumbar spine, whole proximal femur and total body bone mineral density (BMD, g/cm2) and the regional soft tissue composition were measured with dual energy X-ray absorptiometry (Hologic QDR 1000/W) in eight adults with childhood onset GHD, before and after 6 months of recombinant GH treatment (0.5 IU/kg/week). Data obtained from patients were compared with those recorded in an age and sex matched control group. Before treatment, lumbar (L2–L4) spine BMD (mean±SD: 0.811±0.159 g/cm2), whole proximal femur BMD (0.739±0.094 g/cm2) and total body BMD (0.946±0.087 g/cm2) of patients were significantly (p<0.001, 0.01 and 0.001, respectively) lower than those recorded in an age- and sex-matched control group (1.077±0.155 g/cm2, 0.968±0.166 g/cm2 and 1.168±0.058 g/cm2, respectively), although three patients showed BMD values at the lower limit of the normal range. Mean lumbar spine BMD, whole proximal femur BMD and total body BMD did not significantly change alter 6 months’ GH treatment (−1.4±3.7%, +2.7±3.7% and −1.1±5.0% vs basal values, respectively). On the other hand, trochanteric subregion showed a significant 4.8±5.3% increase (vs basal, p<0.05), while other hip subregions did not show significant changes. GH therapy caused marked effects on body composition; in fact, a significant decrease (p<0.01) of trunk fat (−25.2±15.0%) and a marked increase (p<0.01) of limbs lean mass (+10.0±5.3%), resulting in a significant (p<0.02) reduction (−16.5±13.5%) of the axial to peripheral fat ratio (APFR), were clearly evident after six months of therapy. In conclusion, our study shows that six months of GH treatment do not exert relevant effects on the BMD of adults with childhood onset GHD. On the contrary, the effects of GH therapy on body composition are more marked, being clearly appreciable after six months of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brixen K., Nielsen H.K., Mosekilde L., Flyvbjerg A. A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers. J. Bone Miner. Res. 5: 609, 1990.

    Article  CAS  PubMed  Google Scholar 

  2. Brixen K., Kassem M., Eriksen E.F., Nielsen H.K., Flyvbjerg A., Mosekilde L. Growth hormone (GH) and adult bone remodeling: the potential use of GH in the treatment of osteoporosis. J. Pediatr. Endocrinol. 6: 65, 1993.

    Article  CAS  PubMed  Google Scholar 

  3. Ferrandez A., Zachmann M., Prader A., Illig R. Isolated growth hormone deficiency in prepubertal children: influence of human growth hormone on longitudinal growth, adipose tissue, bone mass and bone maturation. Helv. Paediatr. Acta 6: 566, 1970.

    Google Scholar 

  4. Shore R.M., Chesney R.W., Mazees R.B., Rose P.G.F., Bargman G.J. Bone mineral status in growth hormone deficiency. J. Pediatr. 96: 393, 1980.

    Article  CAS  PubMed  Google Scholar 

  5. Kaufman J.M., Taelman P., Vermeulen A., Vandeweghe M. Bone mineral status in growth hormone deficient males with isolated and multiple pituitary deficiencies of childhood onset. J. Clin. Endocrinol. Metab. 74: 118, 1992.

    CAS  PubMed  Google Scholar 

  6. Rosen T., Hansson T., Granhed H., Szucs J., Bengtsson B.A. Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol. (Copenh.) 129: 201, 1993.

    CAS  Google Scholar 

  7. Sartorio A., Conti A., Monzani M. New markers of bone and collagen turnover in children and adults with growth hormone deficiency. Postgrad. Med. J. 69: 846, 1993.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Sartorio A., Conti A., Monzani M., Morabito F., Faglia G. Growth hormone treatment in adults with GH deficiency: effects on new biochemical markers of bone and collagen turnover. J. Endocrinol. Invest. 13: 893, 1993.

    Article  Google Scholar 

  9. Degerblad M., Elgindy N., Hall K., Sjoberg H.E., Thoren M. Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol. (Copenh.) 126: 387, 1992.

    CAS  Google Scholar 

  10. Salomon F., Cuneo R.C., Hesp R., Sonksen P.H. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N. Engl. J. Med. 321: 1797, 1989.

    Article  CAS  PubMed  Google Scholar 

  11. Jorgensen J.O.L., Pedersen S.A., Thuesen L., Jorgensen J., Ingemann-Hansen T., Skakkebaek N.E., Christiansen J.S. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet i: 1221, 1989.

    Article  Google Scholar 

  12. Elgindy N., Grunditz R., Thoren M., Degerblad M., Sjoberg H.E., Ringertz H. Long term follow-up of metacarpal cortical thickness and bone mineral density in panhypopituitarism. Radiol. Diagn. 32: 326, 1991.

    Google Scholar 

  13. O’Halloran D.J., Tsatsoulis A., Whitehouse R.W., Holmes S.J., Adams J.E., Shalet S.M. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J. Clin. Endocrinol. Metab. 76: 1344, 1993.

    PubMed  Google Scholar 

  14. Holmes S.J., Whitehouse R.W., Economou G., O’Halloran D.J., Adams J.E., Shalet S.M. Further increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement. Clin. Endocrinol. (Oxf.) 42: 3, 1995.

    Article  CAS  Google Scholar 

  15. Van Der Veen E.A., Netelembos J.C. Growth hormone (replacement) therapy in adults: bone and calcium metabolism. Horm. Res. 33 (suppl 4): 65, 1990.

    Article  PubMed  Google Scholar 

  16. Orme S.M., Sebastian J.P., Oldroyd B., Steward S.P., Grant P.J., Stickland M.H., Smith M.A., Belchetz P.E. Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy. Clin. Endocrinol. (Oxf.) 37: 453, 1992.

    Article  CAS  Google Scholar 

  17. Whitehead H.M., Boreham C., Mcilrath E.M., Sheridan B., Kennedy L., Atkinson A.B., Hadden D.R. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin. Endocrinol. (Oxf.) 36: 45, 1992.

    Article  CAS  Google Scholar 

  18. Binnerts A., Swart G.R., Wilson J.H.P., Hoogerbrugge N., Pols H.A.P, Birkenhager J.C., Lambers S.W.J. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin. Endocrinol. (Oxf.) 37: 79, 1992.

    Article  CAS  Google Scholar 

  19. Bengtsson B.A., Eden S., Lonn L., Kvist H., Stokland A., Lindstedt G., Bosaeus I., Tolli J., Sjostrom L., Isaksson O.G.P. Treatment of adults with growth hormone deficiency with recombinant human growth hormone. J. Clin. Endocrinol. Metab. 76: 309, 1993.

    CAS  PubMed  Google Scholar 

  20. Beshyah S.A., Freemantle C., Shahi M., Anyaoku V., Merson S., Lynch S., Skinner E., Sharp P., Foale R., Johnston D.G. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults. Clin. Endocrinol. (Oxf.) 42: 73, 1995.

    Article  CAS  Google Scholar 

  21. Mazess R.B., Barden H.S., Bisek J.P., Hanson J. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am. J. Clin. Nutr. 51: 1106, 1990.

    CAS  PubMed  Google Scholar 

  22. Gandolini G.G., Trevisan C., Berino F., Krogh V., Sibilla P., Rainero G., Ortolani S. Fat and lean body mass measured by DXA: short-term precision and comparison with anthropometric parameters. In: First International Symposium on “Osteoporosis and metabolic bone diseases”, International Academic Publishers (ed.), Bejing, 1992, p. 31.

    Google Scholar 

  23. Barnard R., Ng K.W., Martin T.J., Waters M.J. Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH. Endocrinology 128: 1459, 1991.

    Article  CAS  PubMed  Google Scholar 

  24. Ernst M., Froesch E.R. Growth hormone dependent stimulation of osteoblast-like cells in serum free cultures via local synthesis of insulin-like growth factor I. Biochem. Biophys. Res. Commun. 151: 142, 1988.

    Article  CAS  PubMed  Google Scholar 

  25. Marcus R., Butterfield G., Holloway L., Gilliland L., Baylink D.J., Hintz R.L., Sherman B.M. Effects of short term administration of recombinant human growth hormone to elderly people. J. Clin. Endocrinol. Metab. 70: 519, 1990.

    Article  CAS  PubMed  Google Scholar 

  26. Zamboni G., Antoniazzi F., Radetti G., Musumeci C., Tatò L. Effects of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency. J. Pediatr. 119: 483, 1991.

    Article  CAS  PubMed  Google Scholar 

  27. Holmes S.J., Economou G., Whitehouse R.W., Adams J.E., Shalet S.M. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J. Clin. Endocrinol. Metab. 78: 669, 1994.

    CAS  PubMed  Google Scholar 

  28. Bergmann P., Valsamis J., Van Perborgh J., De Schepper J., Van Vliet G. Comparative study of the changes in insulin-like growth factor-I, procollagen-III-N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner’s syndrome treated with recombinant growth hormone. J. Clin. Endocrinol. Metab. 71: 1461, 1990.

    Article  CAS  PubMed  Google Scholar 

  29. Johansson A.G., Lindh E., Ljunghall S. IGFs: function and clinical importance. Growth hormone, insulin-like growth factor I, and bone: a clinical review. J. Intern. Med. 234: 553, 1993.

    Article  CAS  PubMed  Google Scholar 

  30. Vandeweghe M., Taelman P., Kaufman J.M. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin. Endocrinol. (Oxf.) 39: 409, 1993.

    Article  CAS  Google Scholar 

  31. Rutherford O.M., Jones D.A., Round J.M., Buchanan C.R., Preece M.A. Changes in skeletal muscle and body composition after discontinuation of growth hormone treatment in growth hormone deficient young adults. Clin. Endocrinol. (Oxf.) 34: 469, 1991.

    Article  CAS  Google Scholar 

  32. Rosen T., Bengtsson B.A. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet i: 285, 1990.

    Article  Google Scholar 

  33. Sartorio A., Narici M. Growth hormone (GH) treatment in GH-deficient adults: effects on muscle size, strength and neural activation. Clin. Physiol. 14: 527, 1994.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centro Auxologico Italiano, IRCCS, Milano

    A. Sartorio, S. Ortolani, A. Conti, R. Cherubini & E. Galbiati

  2. Istituto di Scienze Endocrine, University of Milan, Milano, Italy

    A. Sartorio, A. Conti & G. Faglia

Authors
  1. A. Sartorio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Ortolani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Conti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Cherubini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Galbiati
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Faglia
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sartorio, A., Ortolani, S., Conti, A. et al. Effects of recombinant growth hormone (GH) treatment on bone mineral density and body composition in adults with childhood onset growth hormone deficiency. J Endocrinol Invest 19, 524–529 (1996). https://doi.org/10.1007/BF03349011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349011

Keywords

Search

Navigation